http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0761679-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 |
filingDate | 1996-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8bec2c4481064cb1d64d6f4c4abb96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afc7bdfcd709c42422cb6b88b05849d6 |
publicationDate | 1997-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0761679-A1 |
titleOfInvention | N-Butylsulfonate esters of estrogens |
abstract | The present invention providesn whereinn X is α-CH 2 OR 1 when A is α-hydro, A and B together are ethylene, and C and D together are ethylene, β-CH 2 OR 1 , or -CO-; R is -H or n-butylsulfonoyl; R 1 is R provided that at least one of R and R 1 must be n-butylsulfonoyl; R 2 is -H, α- or β-hydroxy, or α- or β-n-butylsulfonoyl; A isn B isn C is -CH 2 orn and D is -CH 2 orn methods of inhibiting estrogen deficient patholigies, and pharmaceutical formulations. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7022688-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9825625-A1 |
priorityDate | 1995-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.